These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28624381)

  • 1. In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction.
    Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A; Filipiak KJ; Opolski G; Regar E
    JACC Cardiovasc Interv; 2017 Jul; 10(13):e123-e125. PubMed ID: 28624381
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
    Kang SH; Kang SJ; Kim WJ
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
    [No Abstract]   [Full Text] [Related]  

  • 3. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.
    Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E
    EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
    Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
    Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Evidence of Complete Resorption 4 Years After Bioresorbable Scaffold Implantation in the Setting of ST-Segment Elevation Myocardial Infarction.
    Gori T; Münzel T
    JACC Cardiovasc Interv; 2017 Jan; 10(2):200-202. PubMed ID: 28040446
    [No Abstract]   [Full Text] [Related]  

  • 6. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
    Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
    Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.
    Ochijewicz D; Tomaniak M; Kołtowski L; Rdzanek A; Pietrasik A; Proniewska K; Partyka L; Dijsktra J; Huczek Z; Filipiak K; Opolski G; Kochman J
    Int J Cardiol; 2020 Aug; 312():27-32. PubMed ID: 32315682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 10. Five-Year Optical Coherence Tomography in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents.
    Gomez-Lara J; Brugaletta S; Jacobi F; Ortega-Paz L; Ñato M; Roura G; Romaguera R; Ferreiro JL; Teruel L; Gracida M; Martin-Yuste V; Freixa X; Masotti M; Gomez-Hospital JA; Sabate M; Cequier A
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27702766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolization of Neoatherosclerosis After Percutaneous Coronary Intervention: Insights From Near-Infrared Spectroscopy Imaging and Histopathological Analysis.
    Nishihira K; Otsuka F; Kataoka Y; Asaumi Y; Kaneta K; Nakano H; Ohta-Ogo K; Ishibashi-Ueda H; Noguchi T; Yasuda S
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006175. PubMed ID: 29445002
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioresorbable vascular scaffold for ST elevation myocardial infarction: optical coherence tomography observations at the 2-year follow-up.
    Fam JM; Karanasos A; Regar E; van Geuns RJ
    Coron Artery Dis; 2015 Sep; 26(6):545-7. PubMed ID: 25919904
    [No Abstract]   [Full Text] [Related]  

  • 13. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
    Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 16. An Unusual Complication After Bioresorbable Scaffold Implantation: Visualization of Intramural Hematoma by Optical Coherence Tomography.
    Zhang BC; Karanasos A; Royaards KJ; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2015 Aug; 8(9):e143-e145. PubMed ID: 26292606
    [No Abstract]   [Full Text] [Related]  

  • 17. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial.
    Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V
    Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold: Insights From Optical Coherence Tomography.
    Capranzano P; Francaviglia B; Radu MD; Capodanno D; Di Salvo ME; Tamburino C
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2123-2124. PubMed ID: 30268872
    [No Abstract]   [Full Text] [Related]  

  • 19. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
    Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
    Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.